JETRO Startup
Global Startup Acceleration Program (GSAP) Alumnisカジノ 無料 ゲームnc.
CIC '21 Bio/Healthcare Berkeley SkyDeck '22 Deep Tech (IoT/Robotics/Mobility/Cleantech and others)
Healthcare Biotech
カジノ 無料 ゲームs a cell therapy company providing new cell treatments for leukemia, other blood cancers, and genetic disorders. Celaid’s medium & culturing technology is currently the only technology utilizing chemically defined agents and can expand functional HSCs selectively, which would be a key result for transplantation & ex-vivo HSC gene therapies.
Profile
- Year founded
- 1-Oct-20
- Name of the representative
- Nobuyuki Arakawa / President and CEO
- HQ location（City)
- Tokyo
- Total amount raised to date
- JPY550,000 * updated in Mar.2023 (Unit：JPY thousand, USD mio)
- Stage
- Series A
- Major investors/VCs
- The University of Tokyo Edge Capital Partners Co., Ltd.
- Partnership
- University of Tsukuba
- Major Clients
CEO/Team
*The contents of this page are subject to change without prior notice. Please contact us for the latest information.
